INGRID STRINGA: Open Payments
NPI 1023871811 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,060 in 50 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,462 · 2025 $1,060
Food & beverage: $1,060
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $244 |
| ABBVIE INC. | 10 | $229 |
| Amgen Inc. | 5 | $95 |
| Novo Nordisk Inc | 4 | $78 |
| Lilly USA, LLC | 3 | $65 |
| Neurelis, Inc. | 3 | $55 |
| SK Life Science, Inc. | 2 | $48 |
| LivaNova USA, Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Eisai Inc. | 1 | $31 |
Products named: Fintepla, QULIPTA, OTEZLA, VALTOCO, Briviact, MOUNJARO, Ozempic, UBRELVY.
Industry payments across FL — which companies pay providers there.
